Comparability of patients with type 2 diabetes between the IMEDS Distributed Database and other data sources commonly used for diabetes research: prevalence and demographics
| IMEDS-DD | Other databases | References | |||
| Source | Data | Study period | |||
| Prevalence | |||||
| Population prevalence of type 2 diabetes | 12.6% | 13.0% | Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report10 | National Health and Nutrition Examination Survey (NHANES) | 2013–2016 |
| 13.3% | International Diabetes Federation (IDF) website11 | IDF Diabetes Atlas, 9th edition, 2019 | 2019 | ||
| Demographics of patients with type 2 diabetes | |||||
| Age, years (mean, SD) | 65.0 (13.3) | 63.9 (0.2) | Bailey et al12 | NHANES | 1999–2012 |
| 60.9 (12.8) | Weng et al13 | IBM MarketScan Research Databases | 2015 | ||
| 63.8 (9.5) | Douros et al14 | Canadian Network for Observational Drug Effect Studies: 7 Canadian provincial databases and Clinical Practice Research Datalink (CPRD) | 2013–2018 | ||
| 66.4 (12.3) | Tang et al15 | CPRD | 2012–2014 | ||
| 18–44 | 8.5% | 14.4% | CDC National Diabetes Statistics Report10 | NHANES | 2013–2016 |
| 45–64 | 40.5% | 43.4% | |||
| ≥65 | 51.0% | 41.9% | |||
| Sex: male | 52.8% | 52.5% | CDC National Diabetes Statistics Report10 | NHANES | 2013–2016 |
| 56.4% | McGurnaghan et al16 | Scottish Care Information-Diabetes system (SCI-Diabetes) | 2014–2016 | ||
IMEDS, Innovation in Medical Evidence and Development Surveillance.